2023 年多发性硬化症治疗市场规模估计为 298.4 亿美元,预计到 2031 年将达到 537.7 亿美元;预计到 2031 年的复合年增长率为 6.8%。治疗多发性硬化症的新疗法的开发、药物研发活动的增加以及多发性硬化症病例的增加可能仍是多发性硬化症治疗市场的主要趋势。
多发性硬化症治疗市场分析
这些公司正致力于开发治疗多发性硬化症的各种疗法。例如,2024 年 2 月,罗氏制药印度公司推出了 Ocrevus (Ocrelizumab),这是印度首个也是唯一一个获批的用于治疗复发缓解型多发性硬化症 (RRMS) 和原发性进展型多发性硬化症 (PPMS) 的疾病改良疗法。
多发性硬化症治疗市场概况
多发性硬化症 (MS) 是一种影响中枢神经系统的自身免疫性疾病。免疫系统攻击神经,导致大脑与身体其他部位之间的沟通出现问题。免疫抑制剂和免疫调节剂以及物理疗法被广泛用于治疗 MS。过去几年来,MS疗法不断发展,开发出针对各种机制(包括免疫抑制或免疫调节)的高效疾病改良疗法,并增强免疫细胞隔离。MS 的新兴疗法包括中枢神经系统渗透性布鲁顿酪氨酸激酶抑制剂和自体造血干细胞移植。
战略洞察
多发性硬化症治疗市场驱动因素和机遇
多发性硬化症患病率上升利好市场
根据世界卫生组织 (WHO) 的数据,2023 年全球将有超过 180 万人患有多发性硬化症。此外,根据美国国家多发性硬化症协会的数据,2021 年美国约有 100 万人患有多发性硬化症。根据《南非医学杂志》报道,撒哈拉以南非洲地区的多发性硬化症负担正在增加,2021 年约为 6.1%。截至 2021 年,阿联酋每 10,000 人中就有 7 人(即 684 人)患有多发性硬化症,平均诊断年龄为 28 岁。全球多发性硬化症患病率的增加正在推动多发性硬化症治疗市场的增长。
增加研究经费——多发性硬化症治疗市场的机会
资金的增加正推动全球范围内对多发性硬化症进行广泛的研究,以寻找该疾病的新治疗方法。例如,2023 年 2 月,塔斯马尼亚大学孟席斯医学研究所的研究人员获得了 MS Australia 在多发性硬化症研究资助轮中颁发的研究补助金。他们因 MS 研究获得了 818,966 美元。2023 年 12 月,欧盟将资助国际研究联盟 BEHIND-MS,作为其 HORIZON Europe 计划的一部分,该计划旨在确定特定的生物标志物并开发靶向疗法。该联盟由德国癌症研究中心牵头,将在五年内获得 757 万美元(710 万欧元)的资助。
多发性硬化症治疗市场报告细分分析
有助于多发性硬化症治疗市场分析的关键部分是类型和应用。
- 根据药物类别,多发性硬化症治疗市场分为免疫抑制剂和免疫调节剂。免疫抑制剂部分在 2023 年占据了最大的市场份额。免疫抑制剂是一类抑制或降低人体免疫系统强度的药物。它们被广泛用于治疗自身免疫性疾病。它们还用于降低身体排斥移植器官的能力。多发性硬化症是一种影响中枢神经系统的自身免疫性疾病。免疫抑制疗法是 30 多年来治疗多发性硬化症 (MS) 最常用的治疗方法。常用的 MS 免疫抑制剂是环磷酰胺、硫唑嘌呤、甲氨蝶呤和米托蒽醌。免疫抑制剂是免疫系统成分的抑制剂,用于多发性硬化症的早期治疗。
- 根据给药途径,市场分为注射剂和口服剂。注射剂在 2023 年占据了最大的市场份额。
- 就分销渠道而言,市场分为医院药房、零售药房和电子商务。医院药房部分在 2023 年占据了市场主导地位。
多发性硬化症治疗市场份额按地区分析
多发性硬化症治疗市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美/南美和中美洲。
北美主导着多发性硬化症治疗市场。在北美,美国占据了多发性硬化症治疗市场的很大份额。该国市场的增长主要得益于大量的研发活动、政府、其他私人和非私人研究组织的财政援助、制药公司和技术公司在产品开发方面的合作以及该国多发性硬化症患病率的上升。此外,在预测期内,人们对多发性硬化症治疗结果的认识不断提高,预计将促进产品的采用和接受。此外,在预测期内,批准多发性硬化症治疗的监管政策的实施可能会为市场的增长提供重大机会。预计亚太地区未来几年的复合年增长率最高。CAGR in the coming years.
多发性硬化症治疗市场报告范围
多发性硬化症治疗市场新闻和最新发展
多发性硬化症治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是多发性硬化症治疗和策略市场发展列表:
- 美国食品药品监督管理局批准 Tyruko (natalizumab-sztn),这是 Tysabri (natalizumab) 注射剂的首个生物仿制药,用于治疗复发型多发性硬化症 (MS) 成人患者。(来源:食品药品监督管理局,新闻稿,2023 年)
- Neuraxpharm Group 在欧洲推出了 BRIUMVI (ublituximab),用于治疗患有活动性疾病的复发性多发性硬化症 (RMS) 成人患者。德国是欧洲第一个推出 ublituximab 的国家。此前,Neuraxpharm 于 2023 年 8 月与 TG Therapeutics 达成协议,将 ublituximab 在美国、加拿大、墨西哥以外的地区商业化,但不包括之前合作过的某些亚洲国家。(来源:William Reed,公司网站,2024 年)
多发性硬化症治疗市场报告覆盖范围和交付成果
“多发性硬化症治疗市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
多发性硬化症治疗市场报告分析
复合年增长率(2023 - 2031)6.8%- 2023 年市场规模
298.4 亿美元 - 2031年市场规模
537.7亿美元
报告范围
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 行业格局和竞争分析及最新发展
- 详细的公司简介
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
关键人物;主力;重要一员
- 默克公司
- 诺华公司
- 拜耳公司
- 赛诺菲
- 百时美施贵宝
- Horizon Therapeutics
- 梯瓦制药
- 武田制药
- 霍夫曼-拉罗歇
- 百健(Biogen)
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 免疫抑制剂
- 免疫调节剂
- 注射和口服
- 医院药房
- 零售药店
- 电子商务
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场参与者
多发性硬化症治疗市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 298.4亿美元 |
2031 年市场规模 | 537.7 亿美元 |
全球复合年增长率(2023 - 2031) | 6.8% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按药物类别
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.